Aeglea BioTherapeutics, Inc.

Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recomb…

Biotechnology

US, Austin [HQ]

Summary
IR
Fin. Reports
Financials
Leadership & Strategy
Possible Catalysts

Board & Officers
Business Intelligence
Employee Voice
Mergers and Acquisitions
Qualified Risks
ESG Scores [Soon]

Strategy & Leadership

Mergers & Acquisitions Beta

M&As

AGLE M&As
Biotechnology M&A

M&A Deals · Breakdown

Aeglea BioTherapeutics, Inc. has no acquisition track records yet.

M&A Deals · History

Aeglea BioTherapeutics, Inc. has no acquisition track records yet.